Clearmind Medicine Inc (CMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in thousands)
| 07-2018 | 04-2018 | 01-2018 | 10-2017 | |
| Cash Flows From Operating Activities | ||||
| Accounts receivable | -2 | 1 | -1 | 0 |
| Accounts payable and accrued liabilities | 3 | -5 | 4 | 1 |
| Other Working Capital | 9 | -10 | 3 | -2 |
| Other Operating Activity | -15 | 1 | -27 | -6 |
| Operating Cash Flow | $-5 | $-13 | $-20 | $-7 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -54 | 0 | -5 | -14 |
| Investing Cash Flow | $-54 | $0 | $-5 | $-14 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | -2 | -7 | 170 | 101 |
| Other Financing Activity | -20 | 0 | -6 | 0 |
| Financing Cash Flow | $-22 | $-6 | $164 | $101 |
| Beginning Cash Position | 199 | 222 | 83 | 0 |
| End Cash Position | 116 | 199 | 222 | 80 |
| Net Cash Flow | $-82 | $-20 | $139 | $80 |
| Free Cash Flow | ||||
| Operating Cash Flow | -5 | -13 | -20 | -7 |
| Capital Expenditure | -54 | 0 | -5 | -14 |
| Free Cash Flow | -59 | -13 | -25 | -21 |